biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Money money money

<< Previous

Bullboard Posts

Next >>

Post by OysterBuctoucheon Nov 05, 2020 12:34pm

252 Views

Post# 31842604

Money money money

I understand the long frustration of this suffering share price. I live it. I do see comments from time to time that reflects this...A lot of these comments are unfair (directed at DR). It is common knowledge this company operates with very little cash and a low amount of resources. Pretty tough to move forward at the pace needed when the first concern is likely cash. I will continue to wait this out as we have talented staff and talented Board members who have hung in despite the lack of on hand cash. I am in for the long run. How much money does this little gem need to cross the finish line ?

<< Previous

Bullboard Posts

Next >>

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!